Fast track approvals during disasters

Introduction

Fast track approvals during disasters refer to accelerated administrative, regulatory and legal procedures adopted by governments to approve essential activities, technologies, medicines, medical devices and emergency infrastructure during natural or human-made disasters. These mechanisms are designed to reduce unnecessary administrative delays and ensure that critical resources become available quickly to affected populations.

Disasters such as earthquakes, floods, cyclones, pandemics, industrial accidents and biological emergencies may create an urgent need for medical supplies, vaccines, diagnostic equipment, biotechnology products, emergency healthcare facilities and other essential services. Under ordinary regulatory procedures, obtaining approvals may require extensive documentation, technical assessment and multiple administrative permissions. However, during emergencies, such delays may adversely affect public health, safety and disaster-response operations.

Fast track approvals provide a mechanism for accelerating decision-making without completely abandoning legal safeguards. In biotechnology, these procedures are particularly relevant to emergency vaccine development, diagnostic testing, medical devices, biological products and emergency research activities.

Meaning and objectives of fast track approvals

Fast track approvals are special regulatory procedures through which competent authorities examine and decide applications within shorter timeframes during emergencies.

Their main objective is to balance administrative efficiency with public safety and legal accountability.

The major objectives include:

Rapid response: Accelerating the approval of essential medicines, vaccines and medical technologies.

Public health protection: Ensuring timely availability of critical healthcare products.

Administrative efficiency: Reducing unnecessary procedural delays.

Scientific evaluation: Prioritising applications requiring urgent scientific assessment.

Emergency infrastructure: Facilitating the establishment of temporary hospitals, laboratories and treatment facilities.

Regulatory coordination: Improving cooperation between government departments and approval authorities.

Legal accountability: Maintaining safety standards, documentation and post-approval monitoring.

Fast track approval does not necessarily mean automatic approval. Regulatory authorities must continue to examine relevant safety, quality and efficacy requirements.

Legal framework governing fast track approvals in India

1. Disaster Management Act, 2005

The Disaster Management Act, 2005 establishes the legal framework for disaster preparedness, mitigation, response and recovery in India.

Section 6 empowers the National Disaster Management Authority (NDMA) to lay down policies, plans and guidelines for disaster management.

Section 10 provides functions and powers of the National Executive Committee.

Section 35 establishes the general responsibilities of the Central Government in disaster management.

Section 38 addresses responsibilities of state governments.

These provisions support coordinated governmental action during emergencies, including administrative measures required for essential public services.

2. Epidemic Diseases Act, 1897

The Epidemic Diseases Act, 1897 provides powers to governments to take special measures and prescribe regulations for preventing the outbreak or spread of dangerous epidemic diseases.

Section 2 empowers state governments to adopt special measures and prescribe temporary regulations where ordinary legal provisions are insufficient.

Section 2A provides corresponding powers to the Central Government concerning inspection and preventive measures involving certain conveyances and persons entering or leaving India.

This legislation becomes relevant when emergency public health measures require accelerated administrative decisions.

3. Drugs and Cosmetics Act, 1940

The Drugs and Cosmetics Act, 1940 regulates the import, manufacture, distribution and sale of drugs and applicable medical products.

During public health emergencies, the Central Drugs Standard Control Organisation (CDSCO) may use applicable regulatory mechanisms to prioritise applications for vaccines, medicines and diagnostic products.

However, accelerated review does not eliminate statutory requirements concerning product quality and safety.

4. New Drugs and Clinical Trials Rules, 2019

The New Drugs and Clinical Trials Rules, 2019 establish procedures for clinical trials and regulatory approvals involving new drugs.

The framework allows regulatory authorities to consider applications according to applicable statutory requirements and relevant public health needs.

During emergencies, appropriate prioritisation and accelerated review mechanisms may help facilitate clinical research and access to essential medical products.

5. Environment (Protection) Act, 1986

The Environment (Protection) Act, 1986 establishes the legal framework for environmental protection.

During disasters, temporary infrastructure and emergency industrial activities may require urgent administrative decisions.

However, emergency circumstances do not automatically eliminate environmental obligations. Applicable environmental laws and emergency exemptions must be interpreted according to their specific legal provisions.

Major areas requiring fast track approvals during disasters

1. Emergency vaccine development

During infectious disease outbreaks, vaccines may become essential for preventing widespread illness.

Fast track regulatory procedures can accelerate scientific review, clinical development and manufacturing assessments.

However, safety, quality and efficacy requirements must remain central to the approval process.

2. Emergency diagnostic technologies

Rapid diagnostic kits, molecular testing systems and laboratory equipment may be necessary during biological emergencies.

Accelerated assessment can improve access to essential diagnostic technologies.

3. Medical devices and life-support equipment

Disasters may increase demand for ventilators, oxygen systems, monitoring equipment and other medical devices.

Regulatory authorities may prioritise applications for essential medical equipment to improve healthcare capacity.

4. Biotechnology research facilities

Emergency biological research may require temporary laboratory facilities, specialised equipment and additional institutional permissions.

Fast track procedures can help facilitate legitimate research while maintaining biosafety and institutional oversight.

5. Emergency healthcare infrastructure

Temporary hospitals, medical laboratories, quarantine facilities and specialised treatment centres may require rapid administrative approvals.

Coordination between local authorities, health departments and disaster-management agencies is essential.

6. Agricultural biotechnology

Natural disasters may damage agricultural production and food supplies.

Accelerated assessment of suitable agricultural technologies, seeds and other essential agricultural inputs may help support recovery, subject to applicable regulatory requirements.

Principles governing fast track regulatory approvals

1. Necessity

Accelerated approval should be connected to a genuine emergency or clearly established public interest requirement.

2. Proportionality

Regulatory relaxation should be limited to what is reasonably necessary to address the emergency.

3. Scientific assessment

Essential safety and quality evaluations must be maintained even when administrative timelines are reduced.

4. Transparency

Regulatory authorities should provide clear reasons for accelerated decisions and maintain appropriate records.

5. Accountability

Manufacturers, healthcare institutions and regulatory authorities must remain accountable for compliance with applicable laws.

6. Post-approval monitoring

Products approved through accelerated procedures should remain subject to appropriate monitoring, adverse-event reporting and corrective action.

International legal and regulatory framework

1. World Health Organization (WHO) Emergency Use Listing Procedure

The WHO Emergency Use Listing (EUL) procedure is designed to assess the quality, safety and efficacy of medical products during public health emergencies.

It helps international organisations and countries evaluate essential medical products when ordinary regulatory procedures may not meet urgent public health needs.

2. International Health Regulations, 2005

The International Health Regulations (IHR) provide an international framework for preventing and responding to public health emergencies.

They establish obligations concerning disease surveillance, information sharing and international public health coordination.

3. WTO Agreement on Trade Facilitation

The WTO Agreement on Trade Facilitation promotes faster and more efficient movement, release and clearance of goods across international borders.

Its provisions may support the timely movement of essential medical supplies and emergency equipment during disasters.

4. European Medicines Agency (EMA) accelerated assessment

The EMA provides accelerated assessment procedures for certain medicinal products of major public health interest.

These mechanisms may reduce the time required for regulatory evaluation while maintaining applicable scientific and safety standards.

Important judicial decisions and case laws

1. Paschim Banga Khet Mazdoor Samity v. State of West Bengal (1996)

The Supreme Court examined the failure of government hospitals to provide timely medical treatment to an injured individual.

The Court held that failure to provide adequate emergency medical facilities could violate Article 21 of the Constitution.

It emphasised the government's obligation to provide appropriate medical services.

Relevance: This judgment is important because fast track approvals during disasters may be necessary to ensure timely availability of essential medicines, medical equipment and emergency healthcare infrastructure.

2. Parmanand Katara v. Union of India (1989)

The Supreme Court recognised that preservation of human life is of paramount importance and that medical professionals have an obligation to provide immediate medical assistance in emergency situations.

The Court emphasised that procedural requirements should not obstruct the provision of necessary emergency treatment.

Relevance: The judgment supports the broader principle that administrative procedures should not unnecessarily delay essential medical assistance during emergencies.

3. Association for Democratic Reforms v. Union of India (2024)

The Supreme Court examined constitutional principles concerning transparency and accountability in public affairs while deciding the electoral bonds case.

The Court emphasised the importance of transparency in governmental and institutional processes.

Relevance: Although unrelated to disaster approvals directly, its broader principles are relevant to ensuring that accelerated regulatory decisions remain transparent, reasoned and accountable.

4. M.C. Mehta v. Union of India (1987)

The Supreme Court developed the principle of absolute liability in the context of hazardous industrial activities.

The Court held that enterprises engaged in hazardous or inherently dangerous activities have a stringent responsibility for harm resulting from their operations.

Relevance: Fast track approvals for emergency biotechnology facilities and hazardous industrial activities should not remove the responsibility of organisations to protect public health and environmental safety.

5. Vellore Citizens' Welfare Forum v. Union of India (1996)

The Supreme Court recognised the precautionary principle and polluter-pays principle as important components of Indian environmental law.

It emphasised that environmental protection must remain an essential consideration in development decisions.

Relevance: Emergency regulatory approvals involving biotechnology and industrial infrastructure must consider potential environmental risks and should not treat disaster situations as a general exemption from environmental responsibilities.

Challenges in implementing fast track approvals

1. Reduced assessment time: Accelerated procedures may create difficulties in conducting comprehensive scientific and technical evaluations.

2. Public safety concerns: Inadequately assessed medicines, vaccines or medical devices may create risks for patients.

3. Administrative coordination: Multiple regulatory authorities may have overlapping responsibilities, resulting in confusion and delays.

4. Transparency issues: Emergency decisions may create concerns about preferential treatment or insufficient public disclosure.

5. Environmental risks: Temporary industrial and biotechnology facilities may create environmental concerns if appropriate safeguards are not maintained.

6. Post-approval monitoring: Authorities may face difficulties monitoring products and facilities once emergency approvals have been granted.

7. Regulatory uncertainty: Businesses and research institutions may find it difficult to understand which emergency procedures and exemptions apply.

Safeguards for effective implementation

An effective fast track approval system should incorporate the following safeguards:

Establishing clearly defined emergency approval procedures.

Creating specialised regulatory review committees.

Maintaining essential scientific and clinical safety assessments.

Introducing digital application and approval systems.

Ensuring transparent documentation of regulatory decisions.

Establishing clear timelines for regulatory review.

Conducting post-approval safety monitoring.

Providing independent audits of emergency approvals.

Ensuring coordination between health, environmental and disaster-management authorities.

Introducing corrective measures where approved products subsequently demonstrate safety concerns.

Conclusion

Fast track approvals during disasters are essential regulatory mechanisms for ensuring the timely availability of medicines, vaccines, diagnostic technologies, medical devices and emergency infrastructure. They help governments respond effectively to natural disasters, epidemics and other public emergencies without unnecessary administrative delays.

In India, the Disaster Management Act, 2005, Epidemic Diseases Act, 1897, Drugs and Cosmetics Act, 1940 and New Drugs and Clinical Trials Rules, 2019 provide important legal foundations for emergency administration and healthcare regulation.

Judicial decisions such as Paschim Banga Khet Mazdoor Samity v. State of West Bengal and Parmanand Katara v. Union of India establish important principles concerning emergency medical assistance and the protection of human life.

Ultimately, fast track approvals must balance administrative speed with scientific reliability, transparency, environmental protection and legal accountability. An effective emergency regulatory framework should accelerate essential decisions without compromising public safety or constitutional rights.